Testosterone & Cardiovascular Disease (CVD)

 

The principles of Copenhagen Cardiovascular Clinic (CCC) are based on a pharmacological approach to the treatment of CVD combined with advice and support of life-style changes, specific exercise regimens, and in selected cases, intensive in-clinic therapies.

​

The CVD-Testosterone Connection

 

The sex-hormones (estrogen and testosterone) have a profound influence on the cardiovascular system in both women and men.

 

Several studies have confirmed that men with undetected low testosterone values have higher incidences of hypertension, hyperlipidemia, and diabetes, all of which are related to and part of CVD.  Erectile dysfunction (ED, or male impotence) is another manifestation that is highly correlated to CVD and to low testosterone levels.

​

The evidence from research with both the knowledge of the physiological and biochemical actions of testosterone together with the observed positive clinical effects form the foundation for the supplemental treatment with sex-hormones (estrogen and testosterone) of patients – women and men – with cardiovascular disease and age-related diseases such as type-II diabetes and female menopause and “male menopause” or “andropause.”

​

 

​